相关实验视频
Updated: Feb 21, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
8.3K
新加坡老年人中的多病症组合:使用多诊所数据的横截面研究
Victoria Koh1, Shilpa Tyagi1,2, Gerald Choon-Huat Koh1,2
1MOH Office for Healthcare Transformation (MOHT), Singapore.
Journal of multimorbidity and comorbidity
|February 20, 2026
概括
多种疾病影响了新加坡近60%的老年人.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 多病症,即多种慢性疾病的同时发生,是初级保健中日益关注的问题.
- 现有的研究往往忽视了复杂的多病症组合,超出了二和三.
研究的目的:
- 确定新加坡初级保健机构中老年人多病症的流行率和特定组合.
- 确定针对性干预的常见和昂贵的多病症模式.
主要方法:
- 对50岁及以上50万多名多诊所患者的横截面分析.
- 在23个慢性疾病类别中利用到2012年的诊断来定义多病症.
- 分析了所有观察到的多病症组合及其患病率.
主要成果:
- 近60%的老年人 (59.9%) 呈现多病症.
- 在502,036名患者中发现了超过13,900种独特的多病症组合.
- 最常见的组合涉及3-4种疾病,经常包括高脂血症,高血压和糖尿病.
结论:
- 超脂血症和高血压是流行和昂贵的多病症组合的关键组成部分.
- 目前的疾病特异性管理可能不足;建议优化对常见多病态模式的护理.
相关概念视频
Drug Dosing: Geriatric Patients
306
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
306
Pharmacodynamics in Geriatric Patients: Effects of Age
254
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
254
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
283
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
283
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
744
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
744
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
245
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
245
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
272
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
272

